A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Psychopharmacology

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002130051143PMID 10591870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional Consequences of Central Serotonin Depletion Produced by Repeated Fenfluramine Administration in Rats

  1998cited by this paper
• Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not by fenfluramine

  1998cited by this paper
• In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain

  1998cited by this paper
• MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.

  1998cited by this paper
• Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.

  1998cited by this paper
• Acute Effects of Dexfenfluramine (d‐FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short‐Course, High‐Dose Treatment

  1998cited by this paper
• Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms.

  1998cited by this paper
• Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids

  1997cited by this paper
• Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3,4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramine

  1997cited by this paper
• Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.

  1996cited by this paper
• Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.

  1996cited by this paper
• Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.

  1996cited by this paper
• Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

  1996cited by this paper
• Mechanisms for tolerance to methamphetamine effects.

  1996cited by this paper
• Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions

  1996cited by this paper
• Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.

  1995cited by this paper
• Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.

  1995cited by this paper
• Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)

  1995cited by this paper
• Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines

  1995cited by this paper
• Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.

  1994cited by this paper
• p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) andd-fenfluramine pretreatment attenuatesd-fenfluramine-evoked release of 5-HT in vivo

  1994cited by this paper
• Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.

  1993cited by this paper
• Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.

  1992cited by this paper
• 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.

  1992cited by this paper
• Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.

  1990cited by this paper
• Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

  1990cited by this paper
• A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis.

  1990cited by this paper
• Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.

  1989cited by this paper
• Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.

  1989cited by this paper
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

  1988cited by this paper
• Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine.

  1988cited by this paper
• The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

  1988cited by this paper
• Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

  1988cited by this paper
• 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

  1987cited by this paper
• Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

  1987cited by this paper
• Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

  1987cited by this paper
• Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

  1987cited by this paper
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

  1987cited by this paper
• Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.

  1986cited by this paper
• Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.

  1986cited by this paper
• The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

  1986cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• Evidence that serotonin mediates some behavioral effects of amphetamine.

  1978cited by this paper
• Specificity of a rat behavioral model for serotonin receptor activation.

  1978cited by this paper
• Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine.

  1976cited by this paper
• An animal behavior model for studying central serotonergic synapses.

  1976cited by this paper

• Methcathinone Increases Visually-evoked Neuronal Activity and Enhances Sensory Processing Efficiency in Mice

  2022influential citation
• Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging

  2022cites this paper
• Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse

  2021cites this paper
• Amitriptyline Accelerates SERT Binding Recovery Rate in MDMA-Induced Rat Model: In Vivo 4-[18F]-ADAM PET Imaging

  2021cites this paper
• Drinking to death: Hyponatraemia induced by synthetic phenethylamines.

  2020cites this paper
• Release of antidiuretic hormone (ADH) in response to the administration of synthetic cathinones: the impact orf gender

  2019cites this paper
• Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose

  2019cites this paper
• Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of ±methylenedioxymethamphetamine

  2019cites this paper
• Minocycline attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in the rat brain.

  2019cites this paper
• Title Cognitive Effects of MDMA in Laboratory Animals : A Systematic Review Focusing on Dose Permalink

  2019cites this paper
• Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions

  2018cites this paper
• Amphetamine‐related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

  2017cites this paper
• Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.

  2017cites this paper
• Longitudinal Examination of Learning and Memory in Rats Following Adolescent Exposure to 3,4-Methylenedioxymethamphetamine or 5-Methoxy-N,N-Diisopropyltryptamine

  2017cites this paper
• MDMA and Glutamate: Implications for Hippocampal GABAergic Neurotoxicity

  2016cites this paper
• The role of dopamine D₂ receptor mechanisms in the development of MDMA sensitisation

  2016influential citation
• The role of 5-HT1A and 5-HT1B receptors in MDMA self-administration

  2016cites this paper
• Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

  2016cites this paper
• Repeated administration of the 5-HT1B/1A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT1A and 5-HT1B receptor mechanisms

  2016cites this paper
• Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration

  2016cites this paper
• Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder.

  2015cites this paper
• 3,4-methylenedioxy-methamphetamine(MDMA)-induced increases in hippocampal glutamate concentrations and its impact on the dentate gyrus

  2015cites this paper
• The neurotoxicity of amphetamines during the adolescent period

  2015cites this paper
• Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats.

  2014cites this paper
• The Role of Serotonin in MDMA Self-administration in Rats

  2014influential citation
• Acquisition of MDMA self‐administration: pharmacokinetic factors and MDMA‐induced serotonin release

  2014cites this paper
• A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA.

  2014cites this paper
• Brain and Peripheral Organ Toxicity of "Ecstasy" in Adolescent Rats in Human Relevant Doses

  2014cites this paper
• Prior MDMA exposure inhibits learning and produces both tolerance and sensitization in the radial-arm maze.

  2013cites this paper
• 4-Methyl-amphetamine: a health threat for recreational amphetamine users

  2013influential citation
• Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.

  2013cites this paper
• MDMA ‘ecstasy’ increases cerebral cortical perfusion determined by bolus‐tracking arterial spin labelling (btASL) MRI

  2013cites this paper
• Ecstasy¿s Neurotoxicity: In Vitro Findings from Mitochondria to the Cell

  2013cites this paper
• Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice

  2013cites this paper
• The Role of Trait Impulsivity and Novelty-Seeking as Predisposing Factors to the Acquisition and Reinstatement of MDMA Self-Administration

  2013cites this paper
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Contribution of impulsivity and novelty‐seeking to the acquisition and maintenance of MDMA self‐administration

  2013cites this paper
• Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT

  2013cites this paper
• (±)3,4‐methylenedioxymethamphetamine (“ecstasy”) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain

  2012cites this paper
• Alterations in Peripheral and Central Serotonin Physiologies during Lactation: Relevance to Mood during the Postpartum Period

  2012cites this paper
• The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

  2012cites this paper
• Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

  2012cites this paper
• CANNABINOID RECEPTOR MODULATES MDMA ACUTE RESPONSES AND REINFORCEMENT Abbreviated title : CB 1 receptor and MDMA reward

  2012cites this paper
• MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.

  2011cites this paper
• Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions

  2011cites this paper
• Dopaminergic mechanisms of reinstatement of MDMA‐seeking behaviour in rats

  2011influential citation
• Neuroadaptive Changes in  5-HT1A Autoreceptor Sensitivity  Following High-Dose MDMA Treatment

  2011cites this paper
• The effects of binge MDMA on acquisition and reversal learning in a radial-arm maze task.

  2011cites this paper
• Contributions of serotonin in addiction vulnerability.

  2011influential citation
• Neurotoxicidade da "Ectasy" e dos seus metabolitos em células humanas dopaminérgicas SH-SY5Y

  2010cites this paper
• The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

  2010cites this paper
• The Effects of Acute and Binge 3,4-methylenedioxymethamphetamine (MDMA) Exposure on Learning and Memory in Rats

  2010cites this paper
• PRECLINICAL STUDY: FULL ARTICLE: Tolerance to 3,4‐methylenedioxymethamphetamine is associated with impaired serotonin release

  2010influential citation
• Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET

  2010cites this paper
• Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats

  2010cites this paper
• Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine.

  2010cites this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cites this paper
• MDMA Self-Administration in Laboratory Animals: A Summary of the Literature and Proposal for Future Research

  2009cites this paper
• Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

  2009cites this paper
• Tolerance to the Behavioural and Neurochemical Effects of MDMA Following Repeated Exposure

  2009influential citation
• Efectos conductuales y neuroquímicos del consumo de éxtasis y cocaína en ratones adolescentes.

  2009cites this paper
• Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

  2009influential citation
• The role of Dopamine in the Sensitised Locomotor Activating Effects of Methylenedioxymethamphetamine (MDMA) in Rats

  2009cites this paper
• THE ROLE OF METABOLISM IN ECSTASY-MEDIATED SEROTONERGIC NEUROTOXICITY

  2009cites this paper
• Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.

  2008influential citation
• Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.

  2008cites this paper
• Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.

  2008influential citation
• Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

  2008cites this paper
• Developmental effects of 3,4-methylenedioxymethamphetamine: a review

  2008cites this paper
• The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes

  2008cites this paper
• Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects

  2008cites this paper
• CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.

  2008cites this paper
• B 1 Cannabinoid Receptor Modulates , 4-Methylenedioxymethamphetamine Acute esponses and Reinforcement

  2008cites this paper
• Comparative neuropharmacology of the substituted amphetamines: p-methoxyamphetamine (PMA) & 3,4-methylenedioxymethamphetamine (MDMA)

  2008cites this paper
• Prior Exposure to Chronic Stress and MDMA Potentiates Mesoaccumbens Dopamine Release Mediated by the 5-HT1B Receptor

  2007cites this paper
• Neurobiology of 3,4-Methylenedioxymethamphetamine (MDMA, or ""Ecstasy"")

  2007cites this paper
• MDMA and Other “Club Drugs”

  2007cites this paper
• The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.

  2007cites this paper
• A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

  2007cites this paper
• 3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brain.

  2007cites this paper
• In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p‐methoxyamphetamine (PMA), but not 3,4‐methylenedioxymethamphetamine (MDMA), leads to long‐lasting deficits in serotonin transporter function

  2007cites this paper
• Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.

  2007cites this paper
• The Effect of Catecholamine Depletion by Alpha-Methyl-Para-Tyrosine on Measures of Cognitive Performance and Sleep in Abstinent MDMA Users

  2007cites this paper
• MDMA self‐administration in rats: acquisition, progressive ratio responding and serotonin transporter binding

  2007cites this paper
• The effect of concomitant ecstasy-marijuana use on auditory verbal learning and memory performance

  2007cites this paper
• Experience-dependent changes in temperature and behavioral activity induced by MDMA.

  2006cites this paper
• Ecstasy: Are animal data consistent between species and can they translate to humans?

  2006cites this paper
• Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.

  2006cites this paper
• Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.

  2006cites this paper
• A Behavioural Analysis of Serotonergic Functional Status Following MDMA Exposure

  2006influential citation
• 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

  2006influential citation
• Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain

  2006cites this paper
• Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist

  2006cites this paper
• 3,4‐Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy

  2005cites this paper
• Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine

  2005cites this paper
• Ethanol, 3,4-Methylenedioxymethamphetamine (Ecstasy) and Their Combination: Long-Term Behavioral, Neurochemical and Neuropharmacological Effects in the Rat

  2005cites this paper
• Initial deficit and recovery of function after MDMA preexposure in rats

  2005influential citation
• Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.

  2005cites this paper
• Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.

  2005cites this paper
• Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

  2004influential citation